You are here: Industry Insights > partnership

News List

Charles River & CHDI Extend Partnership contractpharma
April 15, 2019
Five-year extension of their ongoing collaboration that started in 2005 for the drug discovery and development for Huntington’s disease...
Laurus Labs enters into strategic partnership agreement with Global Fund expressbpd
March 27, 2019
Laurus Labs received a maiden TLD order and executed post the USFDA approval in February 2019
Natera and BGI Genomics announce $50M partnership biospectrumasia
March 12, 2019
Natera, Inc. , a leader in cell-free DNA genetic testing, and BGI Genomics Co., Ltd., the largest cell-free DNA clinical testing laboratory in China have announced a $50 million partnership to commercialize Natera's Signatera™ MRD test in China, and to d
BDI - Novartis partnership is announced firstwordpharma
January 21, 2019
Novartis today announced a five-year collaboration with the Big Data Institute (BDI) to establish a world-leading research alliance that will improve drug development by making it more efficient and more targeted.
DNAtrix, Valo Therapeutics Announce Partnership americanpharmaceuticalreview
November 14, 2018
DNAtrix and Valo Therapeutics announced an exclusive R&D collaboration to develop enhanced vaccines using DNAtrix's clinical stage viruses and Valo's proprietary antigenic peptide technology.
AstraZeneca boosts drug discovery through partnership biospectrumasia
October 29, 2018
AstraZeneca boosts drug discovery through partnership
Novartis joins forces with GARDP for better, accessible infectious disease treatments in the developing world pharmafile
September 29, 2018
Novartis has partnered up with the Global Antibiotic Research & Development Partnership (GARDP) to push for faster development and wider availability for children...
Pall, Aetos Biologics Announce Biosimilar Manufacturing Partnership americanpharmaceuticalreview
September 14, 2018
Pall Corporation has announced a strategic partnership between its Pall Biotech business unit and Aetos Biologics, a biosimilar cell line development company.
WuXi Biologics and Inhibrx Enter an Exclusive Partnership for GMP Manufacturing en-cphi.cn
September 11, 2018
The agreement showcases the expansive biologics pipeline of Inhibrx and the world leading technical expertise and capabilities of WuXi Biologics.
Agios, Celgene terminate partnership for developing cancer treatment biospectrum
September 10, 2018
Agios Pharmaceuticals and Celgene have mutually agreed to terminate their collaboration and license agreement inked on April 27, 2015, to develop and commercialize products containing pan-IDH inhibitor AG-881.

Previous page 1 2 3 4 5 6 7 8 Next page